Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its second quarter 2016 financial results before the open of the market on Wednesday, July 20, 2016. Tarek Sherif, chief executive officer, and Rouven Bergmann, chief financial officer, will also hold a conference call at 8:00 a.m. ET for investors and analysts to discuss the Company’s results and business outlook.
To participate by telephone, domestic participants may dial 1-877-303-2528 and international participants may dial 1-847-829-0023. Those interested in participating in the conference call should dial in at least 10 minutes prior to the call to register.
Participants can also join the call via a simultaneous live audio webcast, which will be made available on the “Investor” section of Medidata’s website, http://investor.mdsol.com.
A replay of the conference call can be accessed through August 3, 2016, by dialing 1-800-585-8367 domestically or 1-404-537-3406 internationally, with the passcode 40485281. An archive of the call will also be hosted on the “Investor” section of Medidata’s website, http://investor.mdsol.com, for a limited period of time.
About Medidata
Medidata
is the leading global provider of cloud-based solutions for clinical
research in life sciences, transforming clinical development through its
advanced applications and intelligent data analytics. We are committed
to advancing the competitive and scientific goals of our life sciences
customers worldwide: more than 600 global pharmaceutical companies;
innovative biotech, diagnostic and device firms; leading academic
medical centers; and contract research organizations. Our
industry-leading technology platform, the Medidata Clinical Cloud®,
is the primary technology solution powering clinical trials for 17 of
the world's top 25 global pharmaceutical companies, bringing new levels
of productivity and quality to the clinical testing of promising medical
treatments, from study design and planning through execution, management
and reporting.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160706005339/en/
Contacts:
Investors:
Hulus Alpay,
212-419-1025
halpay@mdsol.com
or
Media:
Nicole
Pariser, 212-659-1069
npariser@mdsol.com